Advanced Medical Isotope Corporation (OTCMKTS:RDGL – Get Free Report) saw a large increase in short interest in the month of October. As of October 15th, there was short interest totaling 3,748 shares. Approximately 0.0% of the shares of the company are sold short. Based on an average trading volume of 2,270,533 shares, the days-to-cover ratio is currently 0.0 days.
Advanced Medical Isotope Stock Performance
OTCMKTS RDGL opened at $0.04 on Monday. Advanced Medical Isotope has a 12 month low of $0.04 and a 12 month high of $0.12. The stock has a market cap of $22.14 million, a price-to-earnings ratio of -4.48 and a beta of -0.45. The company’s 50 day moving average is $0.05 and its two-hundred day moving average is $0.06.
About Advanced Medical Isotope
Advanced Medical Isotope Corp. (OTCMKTS:RDGL) is a medical technology company developing isotope-based treatments for cancer and other localized medical conditions. Its work centers on targeted radiation therapies designed to deliver radioactive material directly to tumors while limiting exposure to surrounding healthy tissue.
The company’s principal product platform is Radiogel, an injectable, biodegradable gel intended to deliver therapeutic radioisotopes locally within solid tumors.
Further Reading
- Five stocks we like better than Advanced Medical Isotope
- Royal Caribbean Buys the Beach as Norwegian Fixes the Ship
- SK hynix Says Memory Demand Beats Supply Through 2030—What It Means for Micron and SanDisk
- STMicroelectronics Could Reach New Highs—Here’s What Needs to Happen
- Marvell Eyes a Swing for the AI Networking Fences as Markets Weigh Lumentum Price Tag
Receive News & Ratings for Advanced Medical Isotope Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Advanced Medical Isotope and related companies with MarketBeat.com's FREE daily email newsletter.
